168 related articles for article (PubMed ID: 22653877)
1. Intestinal transport of aminopterin enantiomers in dogs and humans with psoriasis is stereoselective: evidence for a mechanism involving the proton-coupled folate transporter.
Menter A; Thrash B; Cherian C; Matherly LH; Wang L; Gangjee A; Morgan JR; Maeda DY; Schuler AD; Kahn SJ; Zebala JA
J Pharmacol Exp Ther; 2012 Sep; 342(3):696-708. PubMed ID: 22653877
[TBL] [Abstract][Full Text] [Related]
2. Stereoselective transport of amethopterin enantiomers by the proton-coupled folate transporter.
Narawa T; Itoh T
Drug Metab Pharmacokinet; 2010; 25(3):283-9. PubMed ID: 20610887
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective recognition of amethopterin enantiomers by the rat proton-coupled folate transporter.
Narawa T; Yano T; Itoh T
Biol Pharm Bull; 2015; 38(4):545-51. PubMed ID: 25832635
[TBL] [Abstract][Full Text] [Related]
4. Phase I and pharmacokinetic trial of aminopterin in patients with refractory malignancies.
Ratliff AF; Wilson J; Hum M; Marling-Cason M; Rose K; Winick N; Kamen BA
J Clin Oncol; 1998 Apr; 16(4):1458-64. PubMed ID: 9552052
[TBL] [Abstract][Full Text] [Related]
5. Haem and folate transport by proton-coupled folate transporter/haem carrier protein 1 (SLC46A1).
Laftah AH; Latunde-Dada GO; Fakih S; Hider RC; Simpson RJ; McKie AT
Br J Nutr; 2009 Apr; 101(8):1150-6. PubMed ID: 18782461
[TBL] [Abstract][Full Text] [Related]
6. Sustained inhibition of proton-coupled folate transporter by myricetin.
Furumiya M; Yamashiro T; Inoue K; Nishijima C; Ohta K; Hayashi Y; Yuasa H
Drug Metab Pharmacokinet; 2015 Apr; 30(2):154-9. PubMed ID: 25801697
[TBL] [Abstract][Full Text] [Related]
7. Identification of Tyr residues that enhance folate substrate binding and constrain oscillation of the proton-coupled folate transporter (PCFT-SLC46A1).
Visentin M; Unal ES; Najmi M; Fiser A; Zhao R; Goldman ID
Am J Physiol Cell Physiol; 2015 Apr; 308(8):C631-41. PubMed ID: 25608532
[TBL] [Abstract][Full Text] [Related]
8. Targeting the proton-coupled folate transporter for selective delivery of 6-substituted pyrrolo[2,3-d]pyrimidine antifolate inhibitors of de novo purine biosynthesis in the chemotherapy of solid tumors.
Desmoulin SK; Wang Y; Wu J; Stout M; Hou Z; Fulterer A; Chang MH; Romero MF; Cherian C; Gangjee A; Matherly LH
Mol Pharmacol; 2010 Oct; 78(4):577-87. PubMed ID: 20601456
[TBL] [Abstract][Full Text] [Related]
9. Site-specific contribution of proton-coupled folate transporter/haem carrier protein 1 in the intestinal absorption of methotrexate in rats.
Yokooji T; Mori N; Murakami T
J Pharm Pharmacol; 2009 Jul; 61(7):911-8. PubMed ID: 19589233
[TBL] [Abstract][Full Text] [Related]
10. The monomeric state of the proton-coupled folate transporter represents the functional unit in the plasma membrane.
Duddempudi PK; Nakashe P; Blanton MP; Jansen M
FEBS J; 2013 Jun; 280(12):2900-15. PubMed ID: 23601781
[TBL] [Abstract][Full Text] [Related]
11. Folate malabsorption is associated with down-regulation of folate transporter expression and function at colon basolateral membrane in rats.
Wani NA; Hamid A; Khanduja KL; Kaur J
Br J Nutr; 2012 Mar; 107(6):800-8. PubMed ID: 21861943
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological activity of 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl regioisomers as inhibitors of de novo purine biosynthesis with selectivity for cellular uptake by high affinity folate receptors and the proton-coupled folate transporter over the reduced folate carrier.
Wang L; Cherian C; Kugel Desmoulin S; Mitchell-Ryan S; Hou Z; Matherly LH; Gangjee A
J Med Chem; 2012 Feb; 55(4):1758-70. PubMed ID: 22243528
[TBL] [Abstract][Full Text] [Related]
13. The functional roles of the His247 and His281 residues in folate and proton translocation mediated by the human proton-coupled folate transporter SLC46A1.
Unal ES; Zhao R; Chang MH; Fiser A; Romero MF; Goldman ID
J Biol Chem; 2009 Jun; 284(26):17846-57. PubMed ID: 19389703
[TBL] [Abstract][Full Text] [Related]
14. Unexpected differences in the pharmacokinetics of N-acetyl-DL-leucine enantiomers after oral dosing and their clinical relevance.
Churchill GC; Strupp M; Galione A; Platt FM
PLoS One; 2020; 15(2):e0229585. PubMed ID: 32108176
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological activity of a novel series of 6-substituted thieno[2,3-d]pyrimidine antifolate inhibitors of purine biosynthesis with selectivity for high affinity folate receptors over the reduced folate carrier and proton-coupled folate transporter for cellular entry.
Deng Y; Zhou X; Kugel Desmoulin S; Wu J; Cherian C; Hou Z; Matherly LH; Gangjee A
J Med Chem; 2009 May; 52(9):2940-51. PubMed ID: 19371039
[TBL] [Abstract][Full Text] [Related]
16. A role for the proton-coupled folate transporter (PCFT-SLC46A1) in folate receptor-mediated endocytosis.
Zhao R; Min SH; Wang Y; Campanella E; Low PS; Goldman ID
J Biol Chem; 2009 Feb; 284(7):4267-74. PubMed ID: 19074442
[TBL] [Abstract][Full Text] [Related]
17. The intestinal absorption of folates.
Visentin M; Diop-Bove N; Zhao R; Goldman ID
Annu Rev Physiol; 2014; 76():251-74. PubMed ID: 24512081
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitumor activity of a novel series of 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate inhibitors of purine biosynthesis with selectivity for high affinity folate receptors and the proton-coupled folate transporter over the reduced folate carrier for cellular entry.
Wang L; Cherian C; Desmoulin SK; Polin L; Deng Y; Wu J; Hou Z; White K; Kushner J; Matherly LH; Gangjee A
J Med Chem; 2010 Feb; 53(3):1306-18. PubMed ID: 20085328
[TBL] [Abstract][Full Text] [Related]
19. Stereoselectivity of chiral drug transport: a focus on enantiomer-transporter interaction.
Zhou Q; Yu LS; Zeng S
Drug Metab Rev; 2014 Aug; 46(3):283-90. PubMed ID: 24796860
[TBL] [Abstract][Full Text] [Related]
20. Regulatory mechanisms of intestinal folate uptake in a rat model of folate oversupplementation.
Dev S; Ahmad Wani N; Kaur J
Br J Nutr; 2011 Mar; 105(6):827-35. PubMed ID: 21092376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]